Advanced Search

A Huge Drug Announcement Is Coming This Quarter...

By Jeff Clark
Thursday, November 1, 2007

It happens to every red-blooded American male over the age of 40.
 
You wake up one morning and come face to face with the stark reality that you'll never be a professional athlete. This realization often occurs after a pickup basketball game against the neighborhood college kids... or a Rotary Club softball game where you tried to stretch a blooper single into an extra base hit – and were thrown out by a mile.
 
And it's painful, really painful.
 
Let's face it – chronic pain, whether it's muscular, skeletal, or all in the head, is a side effect of getting old while trying to act young. And when you combine an aging population with the demands of an active lifestyle, you have all the ingredients for a bull market in painkillers.
 
Are sore muscles making it difficult for you to get up in the morning and keep that 9 a.m. appointment? Just pop a pill. Is a backache preventing you from delivering a top-notch presentation? Then pop a pill. Having trouble finishing that report because of carpal tunnel? Pop a pill.
 
Of course, I'm not suggesting that ingesting pain pills is the best or smartest way to keep on schedule.
 
But the fact is that busy people often look for a quick and easy way to get back on track. And most of the time, that leads to prescription painkillers. Unfortunately, a lot of the time, that also leads to addiction.
 
Until now...
 
Pain Therapeutics (PTIE) is completing Phase III clinical trials for its new drug, Remoxy, a non-addictive form of the painkiller oxycodone.
 
Oxycodone is a synthetic form of morphine found in prescription painkillers like Percocet, Percodan, and OxyContin. It's highly addictive.
 
You may recall this is the drug of choice for celebrities including conservative talk show host Rush Limbaugh, Baywatch babe Traci Bingham, and others. It's also quite popular among street thugs, who steal the drug, crush it up – which disables the time-release mechanism – and then down it with a few shots of alcohol, snort it, or even inject it in order to create a powerful high.
 
Pain Therapeutics claims that Remoxy is every bit as effective as other opioid-based painkillers, but without the addictive qualities. The drug resists injection and snorting. And crushing or submerging Remoxy in high-proof alcohol releases just a fraction of the oxycodone contained in the tablet.
 
Results of the Phase III clinical trials are due out sometime this quarter. If the drug lives up to expectations, then this could be the biggest thing for aging, "wanna-be" athletes since 48-year-old George Foreman took on Shannon Briggs in a 1997 heavyweight fight.
 
And it could be a big win for Pain Therapeutics shareholders.
 
Best regards and good trading,
 
Jeff Clark




Recent Articles
Market Notes
Google breaks $700... all-time high.
 
Gold and silver stocks exploding... Newmont Mining, Silver Standard, and Pan American Silver at new highs.
 
Asset managers living the high life... T. Rowe Price, INVESCO, Raymond James, Eaton Vance, and Waddell & Reed hit new highs.
 
The resurgence of Microsoft... world's largest software company at new 52-week high... up 24% in October.
Market Watch
Symbol Price
Change
52-Wk
S&P 500 1221.53 +1.28% +10.12%
Oil 38.31 +1.43% -0.55%
Gold 138.07 +2.12% +16.32%
Silver 28.60 +2.40% +53.60%
US-Dollar 80.67 -0.81% +8.09%
Euro 1.32 +0.64% -12.10%
Volatility 18.01 -7.12% -19.81%
Gold Stocks 581.56 +3.02% +17.04%
10-Year Yield 3.02 +0.67% -10.65%

World ETFs
Symbol Price
Change
52-Wk
USA 122.89 +0.27% +11.33%
Canada 30.50 +0.20% +16.19%
Russia 21.94 +1.43% +18.08%
India 37.85 +0.32% +22.33%
Israel 16.69 +1.34% +10.75%
Japan 10.64 +0.57% +6.51%
Singapore 13.73 -1.08% +18.77%
Taiwan 14.78 +0.41% +19.19%
S. Korea 57.31 +1.33% +23.38%
S. Africa 71.87 +1.44% +28.20%
China 44.42 -1.42% -0.58%
Lat.America 53.17 +0.66% +8.38%

Sector ETFs
Symbol Price
Change
52-Wk
Oil Service 137.59 +1.04% +18.94%
Big Pharma 64.14 +0.02% -3.24%
Internet 72.07 -0.08% +23.41%
Semis 16.22 +1.19% +29.35%
Utilities 31.28 +0.22% +1.46%
Defense 18.52 +0.05% +10.57%
Nanotech 10.03 +0.40% +1.62%
Alt. Energy 10.08 +1.31% -3.26%
Water 18.49 +0.98% +14.49%
Insurance 16.14 +0.44% +21.08%
Biotech 20.54 -0.19% +28.13%
Retail 19.70 +0.25% +30.20%
Software 24.79 +0.81% +25.90%
Big Tech 53.87 +0.26% +22.74%
Construction 13.10 +0.85% +15.72%
Media 13.64 +0.52% +25.95%
Consumer Svcs 67.39 +0.19% +24.54%
Financials 55.04 +0.31% +7.44%
Health Care 64.30 +0.12% +2.01%
Industrials 63.54 +0.46% +21.03%
Basic Mat 74.35 +1.06% +25.27%
Real Estate 55.32 +0.14% +25.02%
Transportation 91.77 +0.66% +26.93%
Telecom 22.59 +0.49% +17.78%